# pBFS Guided High-dose rTMS Therapy for Treatment-Resistant Depression

> **NCT05842291** · NA · SUSPENDED · sponsor: **Changping Laboratory** · enrollment: 60 (estimated)

## Conditions studied

- Treatment-Resistant Depression

## Interventions

- **DEVICE:** Active rTMS with short inter-session interval
- **DEVICE:** Sham rTMS with short inter-session interval
- **DEVICE:** Active rTMS with long inter-session interval

## Key facts

- **NCT ID:** NCT05842291
- **Lead sponsor:** Changping Laboratory
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2023-06-19
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-07-30
- **Target enrollment:** 60 (ESTIMATED)
- **Why stopped:** The project was halted prematurely because of insufficient funds.
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05842291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05842291, "pBFS Guided High-dose rTMS Therapy for Treatment-Resistant Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05842291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*